Replies to post #22952 on Rebus Holdings Inc (RBSH)

[blanka]

POWERBATTLES POSTED THIS

GILEADS remdesivir is a prodrug with the active ingredient is an adenosine analog that may treat lung disease. Nspx owns patent on an adenosine antagonist they also may be used to treat asthma and other lung disorders.

A2b adenosine receptor antagonists for treating cancer
https://patents.google.com/patent/WO2009157938A1/en
Application PCT/US2008/068423 events
2008-06-26
Application filed by Cv Therapeutics, Inc.
2008-06-26
Priority to PCT/US2008/068423
2009-12-30
Publication of WO2009157938A1

A2B receptor antagonist 1 is a potent A2B adenosine receptor antagonist extracted from patent WO 2009157938 A1 EXAMPLE 9B.
https://www.medchemexpress.com/1H-Purine-2,6-dione,_3,9-dihydro-8-[1-_phenylmethyl_-1H-pyrazol-4-yl]-1,3-dipropyl-.html

Recent improvements in the development of A2B adenosine receptor agonists
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583210/

Covid-19 KILL PEOPLE BY ATTACKING THE LUNGS.

Video reveals lung damage in US coronavirus patient: 'People need to take this seriously'

https://www.cnn.com/2020/03/26/health/covid-19-lung-damage-video/index.html

[powerbattles]

Remdesivir resembles the RNA base adenosine "Remdesivir (GS-5734) is a 1'-cyano-substituted adenosine nucleotide analogue prodrug that shows broad-spectrum antiviral activity against several RNA viruses.

https://www.ncbi.nlm.nih.gov/pubmed/30987343